Research

Research

81539 bookmarks
Newest
Statement From Senator Liz Krueger On Senate Passage Of The Marijuana Regulation And Taxation Act | NYSenate.gov
Statement From Senator Liz Krueger On Senate Passage Of The Marijuana Regulation And Taxation Act | NYSenate.gov
Albany - State Senator Liz Krueger released the following statement today following Senate passage of the Marijuana Regulation and Taxation Act (S.854-A):   “Today is an historic day for New Yorkers. I could not be more proud to cast my vote to end the failed policies of marijuana prohibition in our state, and begin the process of building a fair and inclusive legal market for adult-use cannabis. It has been a long road to get here, but it will be worth the wait. The bill we have held out for will create a nation-leading model for legalization.
Statement From Senator Liz Krueger On Senate Passage Of The Marijuana Regulation And Taxation Act | NYSenate.gov
COVID-19 and the endothelium - PMC
COVID-19 and the endothelium - PMC
There is growing evidence that COVID-19 not only affects the lungs but beyond that the endothelial system. Recent studies showed that this can lead to microcirculatory impairments and in consequence to functional disorders of all inner organs. The ...
COVID-19 and the endothelium - PMC
‘A false sense of security’: Experts say delta-8 THC products can still be dangerous | CNN
‘A false sense of security’: Experts say delta-8 THC products can still be dangerous | CNN
Products containing the cannabis compound delta-8 are sometimes marketed as “diet weed” or “light THC,” offering a milder high than what people probably think is in traditional weed products. But the drug can still be dangerous, and an increasing number of users are calling poison centers for help.
‘A false sense of security’: Experts say delta-8 THC products can still be dangerous | CNN
Investigation of clinically acceptable agreement between two methods of automatic measurement of limb occlusion pressure: a randomised trial | BMC Biomedical Engineering | Full Text
Investigation of clinically acceptable agreement between two methods of automatic measurement of limb occlusion pressure: a randomised trial | BMC Biomedical Engineering | Full Text
Background Development of automatic, pneumatic tourniquet technology and use of personalised tourniquet pressures has improved the safety and accuracy of surgical tourniquet systems. Personalisation of tourniquet pressure requires accurate measurement of limb occlusion pressure (LOP), which can be measured automatically through two different methods. The ‘embedded LOP’ method measures LOP using a dual-purpose tourniquet cuff acting as both patient sensor and pneumatic effector. The ‘distal LOP’ method measures LOP using a distal sensor applied to the patient’s finger or toe of the operating limb, using photoplethysmography to detect volumetric changes in peripheral blood circulation. The distal LOP method has been used clinically for many years; the embedded LOP method was developed recently with several advantages over the distal LOP method. While both methods have clinically acceptable accuracy in comparison to LOP measured using the manual Doppler ultrasound method, these two automatic methods have not been directly compared. The purpose of this study is to investigate if the embedded and distal methods of LOP measurement have clinically acceptable agreement. The differences in pairs of LOP measurement in the upper and lower limbs of 81 healthy individuals were compared using modified Bland and Altman analysis. In surgery, it is common for cuff pressure to deviate from the pressure setpoint due to limb manipulation. Surgical tourniquet systems utilise a ± 15 mmHg pressure alarm window, whereby if the cuff pressure deviates from the pressure setpoint by > 15 mmHg, an audiovisual alarm is triggered. Therefore, if the difference (bias) ± SE, 95% CI of the bias and SD of differences ± SE in LOP measurement between the embedded and distal methods were all within ±15 mmHg, this would demonstrate that the two methods have clinically acceptable agreement. Results LOP measurement using the embedded LOP method was − 0.81 ± 0.75 mmHg (bias ± standard error) lower than the distal LOP method. The 95% confidence interval of the bias was − 2.29 to 0.66 mmHg. The standard deviation of the differences ± standard error was 10.35 ± 0.49 mmHg. These results show that the embedded and distal methods of LOP measurement demonstrate clinically acceptable agreement. Conclusions The findings of this study demonstrate clinically acceptable agreement between the embedded and distal methods of LOP measurement. The findings support the use of the embedded LOP method of automatic LOP measurement using dual-purpose tourniquet cuffs to enable accurate, effective and simple prescription of personalised tourniquet cuff pressures in a clinical setting.
Investigation of clinically acceptable agreement between two methods of automatic measurement of limb occlusion pressure: a randomised trial | BMC Biomedical Engineering | Full Text
Rapid testing of red blood cell parameters in primary care patients using HemoScreen™ point of care instrument | BMC Primary Care | Full Text
Rapid testing of red blood cell parameters in primary care patients using HemoScreen™ point of care instrument | BMC Primary Care | Full Text
Background Patients with anemia are frequently encountered in primary care. Once anemia is detected, it is essential to define the type and identify the underlying cause prior to initiation of treatment. In most cases, the cause can be determined using information from the patient history, physical exam, and complete blood counts (CBC). Point of care testing of blood cell counts would speed up the work up of anemia patients. The aim of the present study was to evaluate if the HemoScreen™ instrument (PixCell Medical, Yokneam Ilit, Israel) could be used for primary care samples. It is a POCT instrument that utilizes single sample cuvettes and image analysis of full blood count including RBC, Hemoglobin, MCV, MCH, platelets, WBC, and WBC 5-part differential. Methods We compared the HemoScreen™ and the Sysmex XN instrument results of 100 primary care patient samples focusing on the total white blood cells, red blood cell parameters RBC, Hemoglobin, MCH, MCV and platelets. Results Deming correlations between the HemoScreen™ and the Sysmex XN instruments for the CBC were WBCHemoScreen™ = 1.016* WBCSysmex + 0.34; r = 0.981, RBCHemoScreen™ = 0.988* RBCSysmex + 0.015; r = 0.974, HemoglobinHemoScreen™ = 1.081* HemoglobinSysmex − 11.25; r = 0.964, MCHHemoScreen™ = 0.978* MCHSysmex + 0.78; r = 0.939, MCVHemoScreen™ = 0.963* MCVSysmex + 8.68; r = 0.946, PlateletsHemoScreen™ = 0.964* PlateletsSysmex + 25.7; r = 0.953. Conclusion The HemoScreen™ instrument could provide rapid and accurate test results for evaluation of the red blood cell parameters in primary care. This new technology is interesting as it allows the analysis red blood cell parameters also at small primary care centers.
Rapid testing of red blood cell parameters in primary care patients using HemoScreen™ point of care instrument | BMC Primary Care | Full Text
TECO® Cyprinid Vitellogenin ELISA - Diapharma
TECO® Cyprinid Vitellogenin ELISA - Diapharma
The TECO® Cyprinid Vitellogenin ELISA kit is a sensitive assay for the quantitative determination of vitellogenin in serum, WBH and mucus of cyprinids.
TECO® Cyprinid Vitellogenin ELISA - Diapharma